471 related articles for article (PubMed ID: 22443175)
1. The leukemia associated nuclear corepressor ETO homologue genes MTG16 and MTGR1 are regulated differently in hematopoietic cells.
Ajore R; Kumar P; Dhanda RS; Gullberg U; Olsson I
BMC Mol Biol; 2012 Mar; 13():11. PubMed ID: 22443175
[TBL] [Abstract][Full Text] [Related]
2. The leukemia associated ETO nuclear repressor gene is regulated by the GATA-1 transcription factor in erythroid/megakaryocytic cells.
Ajore R; Dhanda RS; Gullberg U; Olsson I
BMC Mol Biol; 2010 May; 11():38. PubMed ID: 20487545
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional repression by leukaemia-associated ETO family members can be independent of oligomerization and coexpressed hSIN3B and N-CoR.
Olsson A; Olsson I; Dhanda RS
Biochim Biophys Acta; 2008 Oct; 1779(10):590-8. PubMed ID: 18586123
[TBL] [Abstract][Full Text] [Related]
4. The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues.
Dhanda RS; Lindberg SR; Olsson I
BMC Mol Biol; 2008 Jan; 9():8. PubMed ID: 18205948
[TBL] [Abstract][Full Text] [Related]
5. Eto2/MTG16 and MTGR1 are heteromeric corepressors of the TAL1/SCL transcription factor in murine erythroid progenitors.
Cai Y; Xu Z; Xie J; Ham AJ; Koury MJ; Hiebert SW; Brandt SJ
Biochem Biophys Res Commun; 2009 Dec; 390(2):295-301. PubMed ID: 19799863
[TBL] [Abstract][Full Text] [Related]
6. The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation.
Lindberg SR; Olsson A; Persson AM; Olsson I
Exp Hematol; 2005 Feb; 33(2):189-98. PubMed ID: 15676213
[TBL] [Abstract][Full Text] [Related]
7. ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes.
Salat D; Liefke R; Wiedenmann J; Borggrefe T; Oswald F
Mol Cell Biol; 2008 May; 28(10):3502-12. PubMed ID: 18332109
[TBL] [Abstract][Full Text] [Related]
8. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs.
Maiques-Diaz A; Chou FS; Wunderlich M; Gómez-López G; Jacinto FV; Rodriguez-Perales S; Larrayoz MJ; Calasanz MJ; Mulloy JC; Cigudosa JC; Alvarez S
Leukemia; 2012 Jun; 26(6):1329-37. PubMed ID: 22289984
[TBL] [Abstract][Full Text] [Related]
9. Multivalent binding of the ETO corepressor to E proteins facilitates dual repression controls targeting chromatin and the basal transcription machinery.
Guo C; Hu Q; Yan C; Zhang J
Mol Cell Biol; 2009 May; 29(10):2644-57. PubMed ID: 19289505
[TBL] [Abstract][Full Text] [Related]
10. AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor corepressor, an effect that impairs granulocyte differentiation.
Ibañez V; Sharma A; Buonamici S; Verma A; Kalakonda S; Wang J; Kadkol S; Saunthararajah Y
Cancer Res; 2004 Jul; 64(13):4547-54. PubMed ID: 15231665
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the leukaemia-associated ETO homologues of nuclear repressor proteins.
Lindberg SR; Olsson A; Persson AM; Olsson I
Eur J Haematol; 2003 Dec; 71(6):439-47. PubMed ID: 14703694
[TBL] [Abstract][Full Text] [Related]
12. GATA-and SP1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene.
Lecointe N; Bernard O; Naert K; Joulin V; Larsen CJ; Romeo PH; Mathieu-Mahul D
Oncogene; 1994 Sep; 9(9):2623-32. PubMed ID: 8058326
[TBL] [Abstract][Full Text] [Related]
13. Myeloid translocation genes differentially regulate colorectal cancer programs.
Parang B; Bradley AM; Mittal MK; Short SP; Thompson JJ; Barrett CW; Naik RD; Bilotta AJ; Washington MK; Revetta FL; Smith JJ; Chen X; Wilson KT; Hiebert SW; Williams CS
Oncogene; 2016 Dec; 35(49):6341-6349. PubMed ID: 27270437
[TBL] [Abstract][Full Text] [Related]
14. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain.
Amann JM; Nip J; Strom DK; Lutterbach B; Harada H; Lenny N; Downing JR; Meyers S; Hiebert SW
Mol Cell Biol; 2001 Oct; 21(19):6470-83. PubMed ID: 11533236
[TBL] [Abstract][Full Text] [Related]
15. Lineage-restricted regulation of the murine SCL/TAL-1 promoter.
Bockamp EO; McLaughlin F; Murrell AM; Göttgens B; Robb L; Begley CG; Green AR
Blood; 1995 Aug; 86(4):1502-14. PubMed ID: 7632958
[TBL] [Abstract][Full Text] [Related]
16. The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1.
Kitabayashi I; Ida K; Morohoshi F; Yokoyama A; Mitsuhashi N; Shimizu K; Nomura N; Hayashi Y; Ohki M
Mol Cell Biol; 1998 Feb; 18(2):846-58. PubMed ID: 9447981
[TBL] [Abstract][Full Text] [Related]
17. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells.
Müller-Tidow C; Steffen B; Cauvet T; Tickenbrock L; Ji P; Diederichs S; Sargin B; Köhler G; Stelljes M; Puccetti E; Ruthardt M; deVos S; Hiebert SW; Koeffler HP; Berdel WE; Serve H
Mol Cell Biol; 2004 Apr; 24(7):2890-904. PubMed ID: 15024077
[TBL] [Abstract][Full Text] [Related]
18. AML1/ETO oncoprotein is directed to AML1 binding regions and co-localizes with AML1 and HEB on its targets.
Gardini A; Cesaroni M; Luzi L; Okumura AJ; Biggs JR; Minardi SP; Venturini E; Zhang DE; Pelicci PG; Alcalay M
PLoS Genet; 2008 Nov; 4(11):e1000275. PubMed ID: 19043539
[TBL] [Abstract][Full Text] [Related]
19. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
[TBL] [Abstract][Full Text] [Related]
20. Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding site in target promoters.
Barrett CW; Smith JJ; Lu LC; Markham N; Stengel KR; Short SP; Zhang B; Hunt AA; Fingleton BM; Carnahan RH; Engel ME; Chen X; Beauchamp RD; Wilson KT; Hiebert SW; Reynolds AB; Williams CS
PLoS One; 2012; 7(12):e51205. PubMed ID: 23251453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
